Riggs Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23
Closed -$8.95K 345
2025
Q2
$8.95K Buy
23
+18
+360% +$7.24K ﹤0.01% 347
2025
Q1
$2.17K Buy
5
+3
+150% +$1.2K ﹤0.01% 396
2024
Q4
$738 Sell
2
-3
-60% -$1.25K ﹤0.01% 491
2024
Q3
$2.6K Hold
5
﹤0.01% 348
2024
Q2
$2.71K Buy
5
+3
+150% +$1.59K ﹤0.01% 347
2024
Q1
$1.04K Buy
+2
New +$995 ﹤0.01% 415

Other funds holding ELV

Riggs Asset Management's ELV Position: Q3 2025 in Review

Riggs Asset Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 23 shares — an estimated $8.95K sold.

Riggs Asset Management first reported a position in ELV in Q1 2024 and held it in 6 quarters. The position peaked at $8.95K in Q2 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Riggs Asset Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 23 Elevance Health shares in Q3 2025, an estimated $8.95K.
  • Riggs Asset Management first reported a position in Elevance Health in Q1 2024 and held it in 6 quarters.
  • Riggs Asset Management's Elevance Health position peaked at $8.95K in Q2 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.